Worster-Drought Syndrome is a form of cerebral palsy caused by perisylvian brain abnormalities. It features pseudobulbar palsy, impairing speech and swallowing. Managed via multidisciplinary care, treatments include LSVT LOUD and AAC to support communication.

Smith-Lemli-Opitz syndrome is a rare genetic disorder caused by DHCR7 mutations, leading to cholesterol deficiency and toxic oxysterol accumulation. It results in developmental delays and physical malformations. Management involves cholesterol supplementation and therapy.

Kallmann Syndrome and Congenital Hypogonadotropic Hypogonadism result from GnRH deficiency, causing infertility and delayed puberty. Genetic oligogenicity complicates diagnosis. Management focuses on hormone replacement and gonadotropin therapy to restore reproductive health.

Kennedy’s disease (SBMA) is a rare, X-linked disorder caused by AR gene mutations. It triggers progressive muscle wasting, dysphagia, and androgen insensitivity. While no cure exists, research explores ASO therapy and multidisciplinary care to manage its multisystem impact.

Interstitial lung diseases involve inflammation and scarring, often requiring multidisciplinary discussion for accurate diagnosis. Key patterns include UIP and DAD. Monitoring KL-6 levels and spirometry helps track progression. Treatments focus on antifibrotics and steroids.

ALS is a fatal neurodegenerative disease involving motor neuron death. Diagnosis increasingly uses the Gold Coast criteria for higher sensitivity. While Relyvrio was withdrawn, treatments like Tofersen and Riluzole remain. Research now targets SOD1 and TDP-43 mutations.

Research identifies multi-gene signatures to predict liver cancer survival, while global guidelines emphasise ultrasound and biomarkers like AFP for screening. Separately, studies confirm low-dose hydroxychloroquine as an effective treatment for Porphyria Cutanea Tarda.

Arginine vasopressin deficiency (AVP-D) and resistance (AVP-R), formerly called diabetes insipidus, cause severe polyuria and polydipsia. Renaming clarifies the pathology and prevents confusion with diabetes mellitus. Diagnosis uses copeptin-based tests, while treatment relies on desmopressin.

Congenital lung malformations, such as CLE and CPAM, cause respiratory distress through lobar hyperinflation or cystic lesions. CT scans are vital for diagnosis, though fetal ultrasound and MRI provide early detection. Management includes lobectomy or conservative observation.

Williams syndrome and SVAS are caused by ELN gene mutations or 7q11.23 deletions, leading to arterial narrowing. Management requires cardiac screening and specialist anaesthetic planning to prevent ischemia. Surgical repair improves life expectancy but carries risks.